Screener
Nektar Therapeutics NKTR Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 589,041 | 266,266 |
| Long-term investments | 162,993 | — |
| Other assets | 11,237 | 14,140 |
| Total assets | $763,271 | $280,406 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable (including $504 and $137 as of March 31, 2026 and December 31, 2025, respectively, to a related party) | $10,026 | $10,770 |
| Accrued expenses (including $1,148 and $994 as of March 31, 2026 and December 31, 2025, respectively, to a related party) | 25,151 | 22,271 |
Item 1. Condensed Consolidated Financial Statements—Unaudited:
FAQ
- What is Nektar Therapeutics's total assets?
- Nektar Therapeutics (NKTR) reported total assets of $763.27M in Q1 2026.
- How has Nektar Therapeutics's total assets changed year-over-year?
- Nektar Therapeutics's total assets increased by 197.9% year-over-year, from $256.24M to $763.27M.
- What is the long-term trend for Nektar Therapeutics's total assets?
- Over 5 years (2020 to 2025), Nektar Therapeutics's total assets has grown at a -28.9% compound annual growth rate (CAGR), from $1.54B to $280.41M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Nektar Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude